Clinical Trial Update: Aerosol L9-NC and Temozolomide in Ewing's Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial sponsored by MD Anderson Cancer Center evaluating aerosol L9-NC in combination with temozolomide for Ewing's Sarcoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• L9-NC (aerosol) (L9-NC)
• Temozolomide (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ewing's Sarcoma | Phase 1, Phase 2 | Status: COMPLETED